The new excise tax comes when regulatory delays and uncertainty are increasing, and as many device firms are shutting down or moving abroad to take advantage of the more favorable tax and regulatory climate in Europe.
FORBES: ObamaCare's Medical Device Tax Will Cost Innovation and Jobs